5 Key Principles of Modern PK/PD in 2026
Explore other Phoenix solutions to enhance your PK/PD workflow and discover how Phoenix helps you…
CertaraJune 30, 2026
Enhancing clinical trials with real-world evidence in pregnancy research
Learn how real-world evidence improves clinical trials in pregnancy by enhancing safety data, trial design,…
CertaraJune 26, 2026
Certara Launches Bio Venture Catalyst for Emerging Biotechs to De-risk Investment and Accelerate Development
Integrated offering combines drug development, regulatory, commercial, and investor strategy expertise to help early-stage biotech…
Danielle PillsburyJune 23, 2026
63 Runs and No Convergence: When RsNLME Succeeded Where Other PK/PD Solutions Couldn’t
After 63 failed runs on a 16-ODE neutropenia model, RsNLME achieved PK/PD convergence on the…
Stephen DuffullJune 23, 2026
Application of IO Simulator in Immuno-Oncology Combination Therapy: A Small Cell Lung Cancer Case Study
Learn how Certara's IO Simulator was used to predict efficacy, cytokine release syndrome risk, and…
CertaraJune 23, 2026
Mechanistic Modelling of CRS in T-cell Engagers – An Application for Blinatumomab
Discover how Quantitative Systems Pharmacology (QSP) was used to predict cytokine release syndrome risk and…
CertaraJune 23, 2026
Machine Learning-Based Covariate Selection for Population Pharmacokinetic Modeling
Authors: Ibtissem Rebai (Certara), Stephen Duffull (Certara), Ayman Akil (Certara), Anna Largajolli (Certara), Floris Fauchet…
CertaraJune 22, 2026
Machine Learning based drug renal clearance predictor development and application
A machine learning QSAR model predicts human renal clearance from simple, easy-to-obtain inputs and sharpens…
CertaraJune 22, 2026
Accelerating QSP Virtual Population Generation Through Active Learning and Bayesian Optimization
Discover how active learning and Bayesian optimization improve virtual population generation for quantitative systems pharmacology…
CertaraJune 18, 2026
